Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Details) - USD ($)	3 Months Ended		6 Months Ended
STOCKHOLDERS' DEFICIT (Details) - USD ($)	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Total	$ 40,200	$ 99,800	$ 70,900	$ 162,200
Research [Member]
Total	10,400	10,400	20,800	20,800
Product Development [Member]
Total	7,700	15,500	16,800	34,000
Sales And Marketing [Member]
Total	14,900	53,400	14,900	63,300
General And Administrative [Member]
Total	$ 7,200	$ 20,500	$ 18,400	$ 44,100